vimarsana.com

Latest Breaking News On - Chinese national medical products administration - Page 1 : vimarsana.com

China is key market for Singaporean biotech start-up s stomach cancer early diagnosis kit

China is key market for Singaporean biotech start-up s stomach cancer early diagnosis kit
scmp.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scmp.com Daily Mail and Mail on Sunday newspapers.

GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Uproleselan Plus Chemotherapy Misses Phase 3 Trial OS End Point in R/R AML

Uproleselan plus chemotherapy did not achieve a statistically significant improvement in OS vs chemotherapy alone in patients with relapsed/refractory AML.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.